Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder

• Status: Completed
• Trial end date: 2002-08-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a research study comparing the safety and efficacy of two active study medications for the treatment of bipolar I disorder.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Eli Lilly and Company
• Treatments: Olanzapine; Risperidone

Criteria

Inclusion Criteria:

• Male or female subject, 18-70 years of age

• Female subjects of childbearing potential must be using a medically accepted means of contraception

• Each subject must have a level of understanding sufficient to perform all tests and examinations required by the protocol

• Subjects must be considered reliable

Exclusion:

• Female subjects who are either pregnant or nursing

• Uncorrected hypothyroidism or hyperthyroidism

• Narrow-angle glaucoma

• Subjects who present a serious and immediate risk of endangering him or herself